Sponsors: []Modifications: (i)(A)(B)(C)(D)(E)(F)(G)(H) (ii)  Cannabidiol in a drug product that is approved by the United States Food and DrugAdministration. Full text:



1     PHARMACEUTICAL PRODUCT AMENDMENTS2     2017 GENERAL SESSION3     STATE OF UTAH4     Chief Sponsor:  Brian E. Shiozawa5     House Sponsor:  Edward H. Redd6      7     LONG TITLE8     General Description:9           This bill amends a provision related to controlled substances. 10     Highlighted Provisions:11          This bill:12                 provides a schedule in the state Controlled Substances Act for cannabidiol in a drug13     product approved by the United States Food and Drug Administration. 14     Money Appropriated in this Bill:15          None16     Other Special Clauses:17          None18     Utah Code Sections Affected:19     AMENDS:20          58-37-4, as last amended by Laws of Utah 2015, Chapter 25821      22     Be it enacted by the Legislature of the state of Utah:23          Section 1.  Section 58-37-4 is amended to read:24          58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings25     required -- Specific substances included in schedules.26          (1)  There are established five schedules of controlled substances known as Schedules I,27     II, III, IV, and V which consist of substances listed in this section.28          (2)  Schedules I, II, III, IV, and V consist of the following drugs or other substances by29     the official name, common or usual name, chemical name, or brand name designated:30          (a)  Schedule I:31          (i)  Unless specifically excepted or unless listed in another schedule, any of the following32     opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers,33     when the existence of the isomers, esters, ethers, and salts is possible within the specific34     chemical designation:35          (A)  Acetyl-alpha-methylfentanyl36     (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);37          (B)  Acetylmethadol;38          (C)  Allylprodine;39          (D)  Alphacetylmethadol, except levo-alphacetylmethadol also known as40     levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;41          (E)  Alphameprodine;42          (F)  Alphamethadol;43          (G)  Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]44     propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);45          (H)  Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-46     piperidinyl]-N-phenylpropanamide);47          (I)  Benzylpiperazine;48          (J)  Benzethidine;49          (K)  Betacetylmethadol;50          (L)  Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-51     piperidinyl]-N-phenylpropanamide);52          (M)  Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-53     phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;54          (N)  Betameprodine;55          (O)  Betamethadol;56          (P)  Betaprodine;57          (Q)  Clonitazene;58          (R)  Dextromoramide;59          (S)  Diampromide;60          (T)  Diethylthiambutene;61          (U)  Difenoxin;62          (V)  Dimenoxadol;63          (W)  Dimepheptanol;64          (X)  Dimethylthiambutene;65          (Y)  Dioxaphetyl butyrate;66          (Z)  Dipipanone;67          (AA)  Ethylmethylthiambutene;68          (BB)  Etonitazene;69          (CC)  Etoxeridine;70          (DD)  Furethidine;71          (EE)  Hydroxypethidine;72          (FF)  Ketobemidone;73          (GG)  Levomoramide;74          (HH)  Levophenacylmorphan;75          (II)  Morpheridine;76          (JJ)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);77          (KK)  Noracymethadol;78          (LL)  Norlevorphanol;79          (MM)  Normethadone;80          (NN)  Norpipanone;81          (OO)  Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]82     propanamide;83          (PP)  PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);84          (QQ)  Phenadoxone;85          (RR)  Phenampromide;86          (SS)  Phenomorphan;87          (TT)  Phenoperidine;88          (UU)  Piritramide;89          (VV)  Proheptazine;90          (WW)  Properidine;91          (XX)  Propiram;92          (YY)  Racemoramide;93          (ZZ)  Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;94          (AAA)  Tilidine;95          (BBB)  Trimeperidine;96          (CCC)  3-methylfentanyl, including the optical and geometric isomers97     (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and98          (DDD)  3-methylthiofentanyl99     (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).100          (ii)  Unless specifically excepted or unless listed in another schedule, any of the101     following opium derivatives, their salts, isomers, and salts of isomers when the existence of the102     salts, isomers, and salts of isomers is possible within the specific chemical designation:103          (A)  Acetorphine;104          (B)  Acetyldihydrocodeine;105          (C)  Benzylmorphine;106          (D)  Codeine methylbromide;107          (E)  Codeine-N-Oxide;108          (F)  Cyprenorphine;109          (G)  Desomorphine;110          (H)  Dihydromorphine;111          (I)  Drotebanol;112          (J)  Etorphine (except hydrochloride salt);113          (K)  Heroin;114          (L)  Hydromorphinol;115          (M)  Methyldesorphine;116          (N)  Methylhydromorphine;117          (O)  Morphine methylbromide;118          (P)  Morphine methylsulfonate;119          (Q)  Morphine-N-Oxide;120          (R)  Myrophine;121          (S)  Nicocodeine;122          (T)  Nicomorphine;123          (U)  Normorphine;124          (V)  Pholcodine; and125          (W)  Thebacon.126          (iii)  Unless specifically excepted or unless listed in another schedule, any material,127     compound, mixture, or preparation which contains any quantity of the following hallucinogenic128     substances, or which contains any of their salts, isomers, and salts of isomers when the existence129     of the salts, isomers, and salts of isomers is possible within the specific chemical designation; as130     used in this Subsection (2)(a)(iii) only, "isomer" includes the optical, position, and geometric131     isomers:132          (A)  Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;133      -ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole;  -ET; and AET;134          (B)  4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:135     4-bromo-2,5-dimethoxy- -methylphenethylamine; 4-bromo-2,5-DMA;136          (C)  4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:137     2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;138          (D)  2,5-dimethoxyamphetamine, some trade or other names:139     2,5-dimethoxy- -methylphenethylamine; 2,5-DMA;140          (E)  2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;141          (F)  4-methoxyamphetamine, some trade or other names:142     4-methoxy- -methylphenethylamine; paramethoxyamphetamine, PMA;143          (G)  5-methoxy-3,4-methylenedioxyamphetamine;144          (H)  4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:145     4-methyl-2,5-dimethoxy- -methylphenethylamine; "DOM"; and "STP";146          (I)  3,4-methylenedioxy amphetamine;147          (J)  3,4-methylenedioxymethamphetamine (MDMA);148          (K)  3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-149     alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;150          (L)  N-hydroxy-3,4-methylenedioxyamphetamine, also known as151     N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;152          (M)  3,4,5-trimethoxy amphetamine;153          (N)  Bufotenine, some trade and other names:154     3-( -Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,155     N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;156          (O)  Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;157          (P)  Dimethyltryptamine, some trade or other names: DMT;158          (Q)  Ibogaine, some trade and other names:159     7-Ethyl-6,6 ,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino160     [5,4-b] indole; Tabernanthe iboga;161          (R)  Lysergic acid diethylamide;162          (S)  Marijuana;163          (T)  Mescaline;164          (U)  Parahexyl, some trade or other names:165     3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;166          (V)  Peyote, meaning all parts of the plant presently classified botanically as Lophophora167     williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such168     plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such169     plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));170          (W)  N-ethyl-3-piperidyl benzilate;171          (X)  N-methyl-3-piperidyl benzilate;172          (Y)  Psilocybin;173          (Z)  Psilocyn;174          (AA)  Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis175     (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis176     plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,177     and their isomers with similar chemical structure and pharmacological activity to those178     substances contained in the plant, such as the following:  1 cis or trans tetrahydrocannabinol,179     and their optical isomers  6 cis or trans tetrahydrocannabinol, and their optical isomers  3,4 cis180     or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these181     substances is not internationally standardized, compounds of these structures, regardless of182     numerical designation of atomic positions covered;183          (BB)  Ethylamine analog of phencyclidine, some trade or other names:184     N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,185     N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;186          (CC)  Pyrrolidine analog of phencyclidine, some trade or other names:187     1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;188          (DD)  Thiophene analog of phencyclidine, some trade or other names:189     1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and190          (EE)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.191          (iv)  Unless specifically excepted or unless listed in another schedule, any material192     compound, mixture, or preparation which contains any quantity of the following substances193     having a depressant effect on the central nervous system, including its salts, isomers, and salts of194     isomers when the existence of the salts, isomers, and salts of isomers is possible within the195     specific chemical designation:196          (A)  Mecloqualone; and197          (B)  Methaqualone.198          (v)  Any material, compound, mixture, or preparation containing any quantity of the199     following substances having a stimulant effect on the central nervous system, including their200     salts, isomers, and salts of isomers:201          (A)  Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or202     4,5-dihydro-5-phenyl-2-oxazolamine;203          (B)  Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,204     alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;205          (C)  Fenethylline;206          (D)  Methcathinone, some other names: 2-(methylamino)-propiophenone;207     alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;208     alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;209     methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of210     optical isomers;211          (E)  ( )cis-4-methylaminorex (( )cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);212          (F)  N-ethylamphetamine; and213          (G)  N,N-dimethylamphetamine, also known as214     N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.215          (vi)  Any material, compound, mixture, or preparation which contains any quantity of216     the following substances, including their optical isomers, salts, and salts of isomers, subject to217     temporary emergency scheduling:218          (A)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and219          (B)  N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).220          (vii)  Unless specifically excepted or unless listed in another schedule, any material,221     compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate222     (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.223          (b)  Schedule II:224          (i)  Unless specifically excepted or unless listed in another schedule, any of the following225     substances whether produced directly or indirectly by extraction from substances of vegetable226     origin, or independently by means of chemical synthesis, or by a combination of extraction and227     chemical synthesis:228          (A)  Opium and opiate, and any salt, compound, derivative, or preparation of opium or229     opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,230     and their respective salts, but including:231          (I)  Raw opium;232          (II)  Opium extracts;233          (III)  Opium fluid;234          (IV)  Powdered opium;235          (V)  Granulated opium;236          (VI)  Tincture of opium;237          (VII)  Codeine;238          (VIII)  Ethylmorphine;239          (IX)  Etorphine hydrochloride;240          (X)  Hydrocodone;241          (XI)  Hydromorphone;242          (XII)  Metopon;243          (XIII)  Morphine;244          (XIV)  Oxycodone;245          (XV)  Oxymorphone; and246          (XVI)  Thebaine;247          (B)  Any salt, compound, derivative, or preparation which is chemically equivalent or248     identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these249     substances may not include the isoquinoline alkaloids of opium;250          (C)  Opium poppy and poppy straw;251          (D)  Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and252     any salt, compound, derivative, or preparation which is chemically equivalent or identical with253     any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives, and254     salts of isomers and derivatives, whether derived from the coca plant or synthetically produced,255     except the substances may not include decocainized coca leaves or extraction of coca leaves,256     which extractions do not contain cocaine or ecgonine; and257          (E)  Concentrate of poppy straw, which means the crude extract of poppy straw in258     either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium259     poppy.260          (ii)  Unless specifically excepted or unless listed in another schedule, any of the261     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and262     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific263     chemical designation, except dextrorphan and levopropoxyphene:264          (A)  Alfentanil;265          (B)  Alphaprodine;266          (C)  Anileridine;267          (D)  Bezitramide;268          (E)  Bulk dextropropoxyphene (nondosage forms);269          (F)  Carfentanil;270          (G)  Dihydrocodeine;271          (H)  Diphenoxylate;272          (I)  Fentanyl;273          (J)  Isomethadone;274          (K)  Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,275     levomethadyl acetate, or LAAM;276          (L)  Levomethorphan;277          (M)  Levorphanol;278          (N)  Metazocine;279          (O)  Methadone;280          (P)  Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;281          (Q)  Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic282     acid;283          (R)  Pethidine (meperidine);284          (S)  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;285          (T)  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;286          (U)  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;287          (V)  Phenazocine;288          (W)  Piminodine;289          (X)  Racemethorphan;290          (Y)  Racemorphan;291          (Z)  Remifentanil; and292          (AA)  Sufentanil.293          (iii)  Unless specifically excepted or unless listed in another schedule, any material,294     compound, mixture, or preparation which contains any quantity of the following substances295     having a stimulant effect on the central nervous system:296          (A)  Amphetamine, its salts, optical isomers, and salts of its optical isomers;297          (B)  Methamphetamine, its salts, isomers, and salts of its isomers;298          (C)  Phenmetrazine and its salts; and299          (D)  Methylphenidate.300          (iv)  Unless specifically excepted or unless listed in another schedule, any material,301     compound, mixture, or preparation which contains any quantity of the following substances302     having a depressant effect on the central nervous system, including its salts, isomers, and salts of303     isomers when the existence of the salts, isomers, and salts of isomers is possible within the304     specific chemical designation:305          (A)  Amobarbital;306          (B)  Glutethimide;307          (C)  Pentobarbital;308          (D)  Phencyclidine;309          (E)  Phencyclidine immediate precursors: 1-phenylcyclohexylamine and310     1-piperidinocyclohexanecarbonitrile (PCC); and311          (F)  Secobarbital.312          (v) (A)  Unless specifically excepted or unless listed in another schedule, any material,313     compound, mixture, or preparation which contains any quantity of Phenylacetone.314          (B)  Some of these substances may be known by trade or other names:315     phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.316          (vi)  Nabilone, another name for nabilone:317     ( )-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,318     6-dimethyl-9H-dibenzo[b,d]pyran-9-one.319          (c)  Schedule III:320          (i)  Unless specifically excepted or unless listed in another schedule, any material,321     compound, mixture, or preparation which contains any quantity of the following substances322     having a stimulant effect on the central nervous system, including its salts, isomers whether323     optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,324     and salts of isomers is possible within the specific chemical designation:325          (A)  Those compounds, mixtures, or preparations in dosage unit form containing any326     stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were327     listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the328     Code of Federal Regulations, and any other drug of the quantitive composition shown in that329     list for those drugs or which is the same except that it contains a lesser quantity of controlled330     substances;331          (B)  Benzphetamine;332          (C)  Chlorphentermine;333          (D)  Clortermine; and334          (E)  Phendimetrazine.335          (ii)  Unless specifically excepted or unless listed in another schedule, any material,336     compound, mixture, or preparation which contains any quantity of the following substances337     having a depressant effect on the central nervous system:338          (A)  Any compound, mixture, or preparation containing amobarbital, secobarbital,339     pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients340     which are not listed in any schedule;341          (B)  Any suppository dosage form containing amobarbital, secobarbital, or342     pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug343     Administration for marketing only as a suppository;344          (C)  Any substance which contains any quantity of a derivative of barbituric acid or any345     salt of any of them;346          (D)  Chlorhexadol;347          (E)  Buprenorphine;348          (F)  Any drug product containing gamma hydroxybutyric acid, including its salts,349     isomers, and salts of isomers, for which an application is approved under the federal Food,350     Drug, and Cosmetic Act, Section 505;351          (G)  Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:  352     -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;353          (H)  Lysergic acid;354          (I)  Lysergic acid amide;355          (J)  Methyprylon;356          (K)  Sulfondiethylmethane;357          (L)  Sulfonethylmethane;358          (M)  Sulfonmethane; and359          (N)  Tiletamine and zolazepam or any of their salts, some trade or other names for a360     tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:361     2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:362     4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,363     flupyrazapon.364          (iii)  Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a365     U.S. Food and Drug Administration approved drug product, some other names for dronabinol:366     (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or367     (-)-delta-9-(trans)-tetrahydrocannabinol.368          (iv)  Nalorphine.369          (v)  Unless specifically excepted or unless listed in another schedule, any material,370     compound, mixture, or preparation containing limited quantities of any of the following narcotic371     drugs, or their salts calculated as the free anhydrous base or alkaloid:372          (A)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90373     milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of374     opium;375          (B)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90376     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized377     therapeutic amounts;378          (C)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more379     than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline380     alkaloid of opium;381          (D)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more382     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in383     recognized therapeutic amounts;384          (E)  Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90385     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized386     therapeutic amounts;387          (F)  Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than388     15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized389     therapeutic amounts;390          (G)  Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not391     more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in392     recognized therapeutic amounts; and393          (H)  Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with394     one or more active, non-narcotic ingredients in recognized therapeutic amounts.395          (vi)  Unless specifically excepted or unless listed in another schedule, anabolic steroids396     including any of the following or any isomer, ester, salt, or derivative of the following that397     promotes muscle growth:398          (A)  Boldenone;399          (B)  Chlorotestosterone (4-chlortestosterone);400          (C)  Clostebol;401          (D)  Dehydrochlormethyltestosterone;402          (E)  Dihydrotestosterone (4-dihydrotestosterone);403          (F)  Drostanolone;404          (G)  Ethylestrenol;405          (H)  Fluoxymesterone;406          (I)  Formebulone (formebolone);407          (J)  Mesterolone;408          (K)  Methandienone;409          (L)  Methandranone;410          (M)  Methandriol;411          (N)  Methandrostenolone;412          (O)  Methenolone;413          (P)  Methyltestosterone;414          (Q)  Mibolerone;415          (R)  Nandrolone;416          (S)  Norethandrolone;417          (T)  Oxandrolone;418          (U)  Oxymesterone;419          (V)  Oxymetholone;420          (W)  Stanolone;421          (X)  Stanozolol;422          (Y)  Testolactone;423          (Z)  Testosterone; and424          (AA)  Trenbolone.425          (vii)  Anabolic steroids expressly intended for administration through implants to cattle426     or other nonhuman species, and approved by the Secretary of Health and Human Services for427     use, may not be classified as a controlled substance.428          (d)  Schedule IV:429          (i)  Unless specifically excepted or unless listed in another schedule, any material,430     compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not431     less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.432          (ii)  Unless specifically excepted or unless listed in another schedule, any material,433     compound, mixture, or preparation which contains any quantity of the following substances,434     including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and435     salts of isomers is possible within the specific chemical designation:436          (A)  Alprazolam;437          (B)  Barbital;438          (C)  Bromazepam;439          (D)  Butorphanol;440          (E)  Camazepam;441          (F)  Carisoprodol;442          (G)  Chloral betaine;443          (H)  Chloral hydrate;444          (I)  Chlordiazepoxide;445          (J)  Clobazam;446          (K)  Clonazepam;447          (L)  Clorazepate;448          (M)  Clotiazepam;449          (N)  Cloxazolam;450          (O)  Delorazepam;451          (P)  Diazepam;452          (Q)  Dichloralphenazone;453          (R)  Estazolam;454          (S)  Ethchlorvynol;455          (T)  Ethinamate;456          (U)  Ethyl loflazepate;457          (V)  Fludiazepam;458          (W)  Flunitrazepam;459          (X)  Flurazepam;460          (Y)  Halazepam;461          (Z)  Haloxazolam;462          (AA)  Ketazolam;463          (BB)  Loprazolam;464          (CC)  Lorazepam;465          (DD)  Lormetazepam;466          (EE)  Mebutamate;467          (FF)  Medazepam;468          (GG)  Meprobamate;469          (HH)  Methohexital;470          (II)  Methylphenobarbital (mephobarbital);471          (JJ)  Midazolam;472          (KK)  Nimetazepam;473          (LL)  Nitrazepam;474          (MM)  Nordiazepam;475          (NN)  Oxazepam;476          (OO)  Oxazolam;477          (PP)  Paraldehyde;478          (QQ)  Pentazocine;479          (RR)  Petrichloral;480          (SS)  Phenobarbital;481          (TT)  Pinazepam;482          (UU)  Prazepam;483          (VV)  Quazepam;484          (WW)  Temazepam;485          (XX)  Tetrazepam;486          (YY)  Triazolam;487          (ZZ)  Zaleplon; and488          (AAA)  Zolpidem.489          (iii)  Any material, compound, mixture, or preparation of fenfluramine which contains490     any quantity of the following substances, including its salts, isomers whether optical, position,491     or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of492     isomers is possible.493          (iv)  Unless specifically excepted or unless listed in another schedule, any material,494     compound, mixture, or preparation which contains any quantity of the following substances495     having a stimulant effect on the central nervous system, including its salts, isomers whether496     optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,497     isomers, and salts of isomers is possible within the specific chemical designation:498          (A)  Cathine ((+)-norpseudoephedrine);499          (B)  Diethylpropion;500          (C)  Fencamfamine;501          (D)  Fenproprex;502          (E)  Mazindol;503          (F)  Mefenorex;504          (G)  Modafinil;505          (H)  Pemoline, including organometallic complexes and chelates thereof;506          (I)  Phentermine;507          (J)  Pipradrol;508          (K)  Sibutramine; and509          (L)  SPA ((-)-1-dimethylamino-1,2-diphenylethane).510          (v)  Unless specifically excepted or unless listed in another schedule, any material,511     compound, mixture, or preparation which contains any quantity of dextropropoxyphene512     (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.513          (e)  Schedule V:514          (i)  Any compound, mixture, or preparation containing any of the following limited515     quantities of narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid,516     which includes one or more non-narcotic active medicinal ingredients in sufficient proportion to517     confer upon the compound, mixture, or preparation valuable medicinal qualities other than those518     possessed by the narcotic drug alone:519          [(i)] (A)  not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;520          [(ii)] (B)  not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100521     grams;522          [(iii)] (C)  not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100523     grams;524          [(iv)] (D)  not more than 2.5 milligrams of diphenoxylate and not less than 25525     micrograms of atropine sulfate per dosage unit;526          [(v)] (E)  not more than 100 milligrams of opium per 100 milliliters or per 100 grams;527          [(vi)] (F)  not more than 0.5 milligram of difenoxin and not less than 25 micrograms of528     atropine sulfate per dosage unit;529          [(vii)] (G)  unless specifically exempted or excluded or unless listed in another schedule,530     any material, compound, mixture, or preparation which contains Pyrovalerone having a531     stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers;532     and533          [(viii)] (H)  all forms of Tramadol.534           (ii)  Cannabidiol in a drug product that is approved by the United States Food and Drug535     Administration. 

